Key facts
- This page summarizes Alexandria Venture Investments, LLC's Form 4 filing for Singular Genomics Systems, Inc..
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 01 Jun 2021, 17:22.
Alexandria Venture Investments, LLC - 01 Jun 2021 Form 4 Insider Report for Singular Genomics Systems, Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 01 Jun 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Jun 2021, 17:22:47 UTC
- Prior SEC filing
- 26 May 2021
- Next SEC filing
- 21 Oct 2021
- Source filing
- View source filing
- Reporting owner signature
- By: ALEXANDRIA REAL ESTATE EQUITIES, INC., a Maryland corporation, managing member By: /s/ Dean A. Shigenaga Chief Financial Officer
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Alexandria Venture Investments, LLC filed Form 4 for Singular Genomics Systems, Inc. on 01 Jun 2021.
Change
- Previous filing in this sequence was filed on 26 May 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OMIC
transaction
Common stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- +2,645,985
- Change %
- Price
- $0.000000
- Shares after
- 2,645,985
- Date
- 01 Jun 2021
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OMIC
transaction
Derivative
Series A convertible preferred stock
Conversion of derivative security
- Transaction value
- Shares
- -1,796,684
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 01 Jun 2021
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 1,796,684
- Exercise price
- Footnotes
- F1, F2
OMIC
transaction
Derivative
Series B convertible preferred stock
Conversion of derivative security
- Transaction value
- Shares
- -849,301
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 01 Jun 2021
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 849,301
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Alexandria Venture Investments, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
Each share of preferred stock automatically converted into the Issuer's common stock at a ratio of 1 share of preferred stock to 1 share of common stock upon closing of the Issuer's initial public offering on May 26, 2021, for no additional consideration. The shares had no expiration date.
Footnote F2
Not applicable.